These final results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-connected Diseases. Conolidine CONOCB2™ in essence performs https://stewartl517iyq2.dreamyblogs.com/profile